11/6/2023 0 Comments Inner ear itch covidĮxcluding asymptomatic cases, clinical presentations of COVID-19 can range from a mild respiratory infection (common cold–like illness, 80%) to severe pneumonia (14%). Italy was the first European country to experience a dramatic increase in the number of cases, starting in February 2020, facing one of the largest clusters of COVID-19 in Europe. Since then, it has become a public health emergency of unprecedented proportions, caused major restrictions on the everyday lives of billions of people, and strained healthcare systems worldwide. On March 11, 2020, the World Health Organization (WHO) declared the SARS-CoV-2 outbreak a pandemic. It was first identified in Wuhan, a city in the province of Hubei, China, in late December 2019. This is necessary in order to understand if the sudden appearance of an isolated skin rash could justify the routine prescription of home isolation and/or further patient testing to determine the presence or not of a SARS-CoV-2 infection, especially in primary care settings.Ĭoronavirus disease 2019 (COVID-19) is a respiratory illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To this end, it is important to note that skin manifestations are currently reported as rare signs of the disease.įurther research is needed to improve current knowledge about epidemiology, clinical presentation, and pathogenesis of COVID-19 skin manifestations. The probability of a skin rash being an early sign of an underlying SARS-CoV-2 infection should be evaluated in light of the patient’s epidemiological risk profile and the local epidemiological situation. This is particularly true for high-risk populations, even if, to the best of current knowledge, no specific cutaneous manifestation should be considered pathognomonic for COVID-19. To enhance this activity, further research is needed to establish frequency, symptoms, signs, and pathogenesis of skin manifestations in patients with COVID-19.ĭuring the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak, the sudden appearance of a skin rash in a patient with no other etiology to explain its clinical presentation should encourage physicians to consider a possible coronavirus disease 2019 (COVID-19) diagnosis. Early identification of COVID-19 is a key part of the strategy of case detection and case isolation. In light of recent studies, this case report suggests that skin manifestations, when taken into account with other situational factors (such as profession and patient history) should be taken into proper consideration by frontline physicians as possibly being caused by SARS-CoV-2. Her skin manifestations disappeared completely 48 days after the onset of the disease, followed by the disappearance of the dry cough. During the first week of remote assessment carried out by her general practitioner, the patient gradually developed a dry cough, intermittent fever, and diarrhoea and then had a positive test result for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The rash was accompanied by a feeling of general fatigue that gradually worsened over the following days and has continued for 5 months (until the end of July 2020). On March 13, 2020, the patient developed an itchy, erythematous papular rash (sparing only her face, scalp, and abdomen), which lasted for 10 days. The patient is an Italian 32-year-old female nurse who had several close contacts with multiple patients with COVID-19 as part of her professional workload. The purpose of this case report is to bring attention to skin manifestations in the early stage of COVID-19 in order to support frontline physicians in their crucial activity of case identification. Several recent studies suggest the possibility of a skin rash being a clinical presentation of coronavirus disease 2019 (COVID-19).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |